Literature DB >> 15452302

The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis.

S A Morrow1, C A Stoian, J Dmitrovic, S C Chan, L M Metz.   

Abstract

Oral prednisone (1)might be a convenient, inexpensive alternative to IV methylprednisolone (IVMP) if the bioequivalent dose was known. We compared the total amount of steroid absorbed after 1250 mg oral prednisone vs 1 gram IVMP in 16 patients with multiple sclerosis (MS). At 24 hours, the mean area under the concentration-time curve (AUC), the main component of bioavailability, did not differ between groups (p = 0.122). This suggests that the amount of absorbed corticosteroid is similar after either steroid at these doses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452302     DOI: 10.1212/01.wnl.0000138572.82125.f5

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  19 in total

1.  A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy.

Authors:  Pietro Annovazzi; Valentina Tomassini; Benedetta Bodini; Laura Boffa; Massimiliano Calabrese; Eleonora Cocco; Cinzia Cordioli; Giovanna De Luca; Giovanni Frisullo; Antonio Gallo; Simona Malucchi; Damiano Paolicelli; Ilaria Pesci; Marta Radaelli; Paolo Ragonese; Luca Roccatagliata; Carla Tortorella; Marco Vercellino; Valentina Zipoli; Claudio Gasperini; Mariaemma Rodegher; Claudio Solaro
Journal:  Neurol Sci       Date:  2012-03-11       Impact factor: 3.307

Review 2.  Diagnosis and treatment of multiple sclerosis.

Authors:  T J Murray
Journal:  BMJ       Date:  2006-03-04

3.  Acute demyelinating disorders of the central nervous system.

Authors:  Meghan K Harris; Amir Hadi Maghzi; Masoud Etemadifar; Roger E Kelley; Eduardo Gonzalez-Toledo; Alireza Minagar
Journal:  Curr Treat Options Neurol       Date:  2009-01       Impact factor: 3.598

Review 4.  Corticosteroids and plasma exchange in multiple sclerosis.

Authors:  Hayretin Tumani
Journal:  J Neurol       Date:  2008-12       Impact factor: 4.849

5.  Assessing relapses and response to relapse treatment in patients with multiple sclerosis: a nursing perspective.

Authors:  Amy Perrin Ross; June Halper; Colleen J Harris
Journal:  Int J MS Care       Date:  2012

6.  Pediatric multiple sclerosis.

Authors:  Yashma Patel; Vikram Bhise; Lauren Krupp
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

7.  Treatment of pediatric multiple sclerosis.

Authors:  Sona Narula; Sarah E Hopkins; Brenda Banwell
Journal:  Curr Treat Options Neurol       Date:  2015-03       Impact factor: 3.598

Review 8.  Glucocorticoid treatment in juvenile idiopathic arthritis.

Authors:  Ezgi Deniz Batu
Journal:  Rheumatol Int       Date:  2018-10-01       Impact factor: 2.631

Review 9.  Corticosteroids for multiple sclerosis: I. Application for treating exacerbations.

Authors:  Elliot M Frohman; Anjali Shah; Eric Eggenberger; Luanne Metz; Robert Zivadinov; Olaf Stüve
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

10.  Randomized clinical trial comparing oral prednisone (50 mg) with placebo before laparoscopic cholecystectomy.

Authors:  Thue Bisgaard; Svend Schulze; Niels Christian Hjortsø; Jacob Rosenberg; Viggo Bjerregaard Kristiansen
Journal:  Surg Endosc       Date:  2007-12-20       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.